BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14978238)

  • 1. Caffeic acid esters activate TREK-1 potassium channels and inhibit depolarization-dependent secretion.
    Danthi S; Enyeart JA; Enyeart JJ
    Mol Pharmacol; 2004 Mar; 65(3):599-610. PubMed ID: 14978238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREK-1 K+ channels couple angiotensin II receptors to membrane depolarization and aldosterone secretion in bovine adrenal glomerulosa cells.
    Enyeart JA; Danthi SJ; Enyeart JJ
    Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1154-65. PubMed ID: 15315905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin induces the expression of TREK-1 mRNA and K+ current in adrenocortical cells.
    Enyeart JA; Danthi S; Enyeart JJ
    Mol Pharmacol; 2003 Jul; 64(1):132-42. PubMed ID: 12815169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of native TREK-1 and Kv1.4 K+ channels by polyunsaturated fatty acids and lysophospholipids.
    Danthi S; Enyeart JA; Enyeart JJ
    J Membr Biol; 2003 Oct; 195(3):147-64. PubMed ID: 14724761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of native TREK-1 K+ channels by selected dihydropyridine Ca2+ channel antagonists.
    Liu H; Enyeart JA; Enyeart JJ
    J Pharmacol Exp Ther; 2007 Oct; 323(1):39-48. PubMed ID: 17622574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for cAMP-independent bTREK-1 inhibition by ACTH and NPS-ACTH in adrenocortical cells.
    Enyeart JJ; Liu H; Enyeart JA
    Mol Cell Endocrinol; 2012 Jan; 348(1):305-12. PubMed ID: 21952081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACTH inhibits bTREK-1 K+ channels through multiple cAMP-dependent signaling pathways.
    Liu H; Enyeart JA; Enyeart JJ
    J Gen Physiol; 2008 Aug; 132(2):279-94. PubMed ID: 18663135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-substituted cAMP analogs inhibit bTREK-1 K+ channels and stimulate cortisol secretion by a protein kinase A-independent mechanism.
    Liu H; Enyeart JA; Enyeart JJ
    Mol Pharmacol; 2009 Dec; 76(6):1290-301. PubMed ID: 19734321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ACTH- and ATP-regulated background K+ channel in adrenocortical cells is TREK-1.
    Enyeart JJ; Xu L; Danthi S; Enyeart JA
    J Biol Chem; 2002 Dec; 277(51):49186-99. PubMed ID: 12368289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual pharmacological properties of a cyclic AMP-sensitive potassium channel.
    Gomora JC; Enyeart JJ
    J Pharmacol Exp Ther; 1999 Jul; 290(1):266-75. PubMed ID: 10381786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II inhibits native bTREK-1 K+ channels through a PLC-, kinase C-, and PIP2-independent pathway requiring ATP hydrolysis.
    Liu H; Enyeart JA; Enyeart JJ
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C682-95. PubMed ID: 17494631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ and K+ channels of normal human adrenal zona fasciculata cells: properties and modulation by ACTH and AngII.
    Enyeart JJ; Enyeart JA
    J Gen Physiol; 2013 Aug; 142(2):137-55. PubMed ID: 23858003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin inhibits bTREK-1 K+ channels and stimulates cortisol secretion from adrenocortical cells.
    Enyeart JA; Liu H; Enyeart JJ
    Biochem Biophys Res Commun; 2008 Jun; 370(4):623-8. PubMed ID: 18406348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACTH-induced Cl(-) current in bovine adrenocortical cells: correlation with cortisol secretion.
    Dupré-Aucouturier S; Penhoat A; Rougier O; Bilbaut A
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E355-65. PubMed ID: 11788367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of TREK-2 in insulin-secreting MIN6 cells.
    Kang D; Choe C; Kim D
    Biochem Biophys Res Commun; 2004 Oct; 323(1):323-31. PubMed ID: 15351740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-dependent inhibition of adrenal TREK-1 channels by angiotensin II and ionomycin.
    Enyeart JJ; Liu H; Enyeart JA
    Am J Physiol Cell Physiol; 2011 Sep; 301(3):C619-29. PubMed ID: 21613605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II inhibits bTREK-1 K+ channels in adrenocortical cells by separate Ca2+- and ATP hydrolysis-dependent mechanisms.
    Enyeart JJ; Danthi SJ; Liu H; Enyeart JA
    J Biol Chem; 2005 Sep; 280(35):30814-28. PubMed ID: 15994319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stretch-activated potassium channel TREK-1 in rat cardiac ventricular muscle.
    Xian Tao Li ; Dyachenko V; Zuzarte M; Putzke C; Preisig-Müller R; Isenberg G; Daut J
    Cardiovasc Res; 2006 Jan; 69(1):86-97. PubMed ID: 16248991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP analogs and their metabolites enhance TREK-1 mRNA and K+ current expression in adrenocortical cells.
    Enyeart JA; Liu H; Enyeart JJ
    Mol Pharmacol; 2010 Mar; 77(3):469-82. PubMed ID: 20028740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.
    Gong YZ; Ding WG; Wu J; Tsuji K; Horie M; Matsuura H
    Eur J Pharmacol; 2008 Dec; 600(1-3):18-25. PubMed ID: 18930721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.